| FCVCX | VISVX | FCVCX / VISVX | |
| Total Expense Ratio | 1.95 | 0.19 | 1,026% |
| Annual Report Gross Expense Ratio | 1.95 | 0.19 | 1,026% |
| Fund Existence | 21 years | 28 years | - |
| Gain YTD | 6.063 | 6.555 | 92% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.68B | 59.8B | 8% |
| Annual Yield % from dividends | 0.49 | 1.74 | 28% |
| Returns for 1 year | -0.56 | 12.01 | -5% |
| Returns for 3 years | 0.45 | 29.81 | 2% |
| Returns for 5 years | 5.33 | 51.01 | 10% |
| Returns for 10 years | 18.29 | 161.74 | 11% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NBRTX | 27.37 | 0.07 | +0.26% |
| Neuberger M/C Intrinsic Val Inst | |||
| JMVQX | 32.04 | 0.06 | +0.19% |
| JPMorgan Mid Cap Value R4 | |||
| KMKAX | 76.91 | -0.17 | -0.22% |
| Kinetics Market Opportunities Adv A | |||
| BGIVX | 14.88 | -0.11 | -0.76% |
| Baillie Gifford International Alpha 5 | |||
| MMCGX | 23.42 | -0.41 | -1.72% |
| Morgan Stanley Inst Discovery R6 | |||